TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 156 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $50,457,000 | +227.2% | 670,522 | +16.7% | 0.01% | +250.0% |
| Q1 2022 | $15,421,000 | -4.3% | 574,372 | +70.1% | 0.00% | 0.0% |
| Q4 2021 | $16,110,000 | +500.0% | 337,760 | +736.0% | 0.00% | – |
| Q3 2021 | $2,685,000 | -36.1% | 40,403 | -25.0% | 0.00% | -100.0% |
| Q2 2021 | $4,204,000 | +537.0% | 53,882 | +672.7% | 0.00% | – |
| Q1 2021 | $660,000 | -89.4% | 6,973 | -86.3% | 0.00% | -100.0% |
| Q4 2020 | $6,219,000 | +652.0% | 51,038 | +439.1% | 0.00% | – |
| Q3 2020 | $827,000 | -3.0% | 9,467 | -28.3% | 0.00% | – |
| Q2 2020 | $853,000 | +480.3% | 13,210 | +301.8% | 0.00% | – |
| Q1 2020 | $147,000 | -93.9% | 3,288 | -91.5% | 0.00% | -100.0% |
| Q4 2019 | $2,409,000 | +667.2% | 38,678 | +364.0% | 0.00% | – |
| Q3 2019 | $314,000 | +6180.0% | 8,336 | +7148.7% | 0.00% | – |
| Q2 2019 | $5,000 | – | 115 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |